查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1655343

全球疟疾诊断市场

Malaria Diagnostics
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 162 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年全球疟疾诊断市场规模将达 13 亿美元

2024 年全球疟疾诊断市场规模估计为 9.017 亿美元，预计 2030 年将达到 13 亿美元，2024-2030 年分析期间的复合年增长率为 5.6%。快速诊断测试是报告中分析的细分市场之一，预计到分析期结束时复合年增长率为 5.7%，达到 6.859 亿美元。在分析期内，显微镜诊断部分预计将以 4.9% 的复合年增长率成长。

美国市场规模估计为 2.333 亿美元，中国市场预计复合年增长率为 8.6%

预计 2024 年美国疟疾诊断市场价值将达到 2.333 亿美元。中国是世界第二大经济体，预计到 2030 年市场规模将达到 2.9 亿美元，2024-2030 年分析期间的复合年增长率为 8.6%。其他值得注意的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为 3.3% 和 4.5%。在欧洲，德国的复合年增长率预计为 4.2%。

全球疟疾诊断市场 - 主要趋势与驱动因素摘要

在对抗这种地方性疾病的过程中，疟疾诊断技术有何发展？

疟疾诊断对于全球对抗最受欢迎的寄生虫疾病至关重要，特别是在撒哈拉以南非洲和东南亚等地区。准确、早期发现疟疾对于有效治疗疟疾、防止严重併发症和死亡至关重要。显微镜和快速诊断测试（RDT）等传统诊断方法长期以来一直是疟疾诊断的黄金标准。然而，诊断技术的进步正在提高这些测试的准确性、速度和可用性。聚合酵素链锁反应（PCR）测试等新的分子诊断工具提高了灵敏度，可以检测到传统方法可能遗漏的低水平寄生虫。诊断技术的进步对于继续全球消除疟疾和改善患者治疗效果的努力至关重要。

哪些技术创新正在改变疟疾诊断？

技术创新在疟疾诊断方面取得了巨大进步，提高了其准确性和可近性。最显着的进展之一是可携式分子检测设备的引入，它可以在偏远和资源有限的环境中进行高度准确的检测。利用环介导等恒温环型核酸扩增(LAMP) 等技术，这些测试可以提供快速的结果，而无需大规模的测试基础设施。此外，数位显微镜的进步可以自动检测寄生虫，减少人为错误并提高诊断工作流程的效率。人工智慧和机器学习在诊断中的应用进一步改善了对测试结果的解释，使临床医生能够就疟疾治疗做出更快、更可靠的决策。

在资源有限的地区，疟疾诊断面临哪些挑战？

儘管疟疾诊断技术取得了进展，但在资源有限的地区部署这些工具仍面临挑战。一个主要问题是先进诊断技术的成本和复杂性，这可能会限制其在疟疾最流行的偏远地区的使用。显微镜和 RDT 等传统方法虽然具有成本效益，但需要熟练的人员，并且仍可能错过低水平感染。另一个挑战是在疫情爆发期间维持诊断材料的供应链并确保难以到达的地区能够进行检测。此外，不同地区的诊断品质存在差异，培训和设备也不一致，阻碍了实现普遍获得可靠的疟疾诊断的努力。消除这些障碍对于改善疟疾控制并最终减轻流行地区的疾病负担至关重要。

疟疾诊断市场的成长将受到多种因素的推动

疟疾诊断市场的成长受到多种因素的推动，包括流行地区疟疾盛行率的增加、诊断技术的进步以及全球消除疟疾的努力。携带式分子诊断和人工智慧工具等技术创新正在扩大准确和及时诊断的机会，即使在医疗保健基础设施有限的地区也是如此。政府和非政府组织为消除疟疾而增加的资金也加速了改进诊断方法的采用。此外，人们越来越意识到早期检测对于预防疟疾导致的严重疾病和死亡的重要性，这也推动了对更可靠、更有效的检测解决方案的需求。这些因素加上正在进行的研究和开发努力，预计将推动疟疾诊断市场的持续成长。

部分

细分领域（快速诊断测试、显微镜检查、分子诊断）

受访公司范例（16家值得关注的公司）

  • 1-800MD
  • Access Bio, Inc.
  • AlphaHelix Technologies AB
  • AmeriPath, Inc.
  • Apollo Diagnostics
  • Biocan Diagnostics
  • Biohelix
  • bioMerieux Sweden AB
  • Bioperfectus Technologies
  • Biotype Diagnostics

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章 市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲国家
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP13150

Global Malaria Diagnostics Market to Reach US$1.3 Billion by 2030

The global market for Malaria Diagnostics estimated at US$901.7 Million in the year 2024, is expected to reach US$1.3 Billion by 2030, growing at a CAGR of 5.6% over the analysis period 2024-2030. Rapid Diagnostic Tests, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$685.9 Million by the end of the analysis period. Growth in the Microscopic Diagnostics segment is estimated at 4.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$233.3 Million While China is Forecast to Grow at 8.6% CAGR

The Malaria Diagnostics market in the U.S. is estimated at US$233.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$290.0 Million by the year 2030 trailing a CAGR of 8.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.3% and 4.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.2% CAGR.

Global Malaria Diagnostics Market - Key Trends & Drivers Summarized

How Are Malaria Diagnostics Evolving in the Fight Against This Endemic Disease?

Malaria diagnostics are crucial in the global fight against one of the most prevalent parasitic diseases, particularly in regions like sub-Saharan Africa and Southeast Asia. Accurate and early detection of malaria is essential to effectively treating the disease and preventing severe complications or death. Traditional diagnostic methods like microscopy and rapid diagnostic tests (RDTs) have long been the gold standard in malaria diagnosis. However, advances in diagnostic technologies are improving the accuracy, speed, and accessibility of these tests. New molecular diagnostic tools, such as polymerase chain reaction (PCR) testing, have enhanced sensitivity and can detect low parasite levels that are often missed by conventional methods. The evolution of diagnostic techniques is vital in the ongoing global efforts to eliminate malaria and improve patient outcomes.

What Technological Innovations Are Transforming Malaria Diagnostics?

Technological innovations are driving significant advancements in malaria diagnostics, improving their accuracy and accessibility. One of the most notable developments is the introduction of portable molecular testing devices, which allow for highly accurate detection in remote or resource-limited settings. These devices, which use techniques like loop-mediated isothermal amplification (LAMP), can provide results quickly without requiring extensive laboratory infrastructure. Additionally, advancements in digital microscopy have enabled automated parasite detection, reducing human error and increasing the efficiency of diagnostic workflows. The integration of AI and machine learning in diagnostics has further improved the interpretation of test results, helping clinicians make faster and more reliable decisions regarding malaria treatment.

What Are the Challenges Facing Malaria Diagnostics in Resource-Limited Areas?

Despite the progress in malaria diagnostics, there are several challenges in deploying these tools in resource-limited areas. One major issue is the cost and complexity of advanced diagnostic methods, which can limit their availability in remote regions where malaria is most prevalent. Traditional methods like microscopy and RDTs, while cost-effective, require skilled personnel and can still miss low-level infections. Another challenge is maintaining the supply chain for diagnostic materials and ensuring that tests are available in hard-to-reach areas during outbreaks. Additionally, the variability in diagnostic quality across regions, driven by inconsistent training and equipment, hinders efforts to achieve universal access to reliable malaria diagnostics. Addressing these barriers is critical for improving malaria management and ultimately reducing the disease burden in endemic areas.

Growth in the Malaria Diagnostics Market Is Driven by Several Factors

The growth in the malaria diagnostics market is driven by several factors, including the increasing prevalence of malaria in endemic regions, advancements in diagnostic technologies, and global efforts toward malaria elimination. Technological innovations such as portable molecular diagnostics and AI-driven tools are expanding access to accurate and timely diagnostics in areas with limited healthcare infrastructure. The rise in funding from governmental and non-governmental organizations aimed at combating malaria is also accelerating the adoption of improved diagnostic methods. Furthermore, the growing awareness of the importance of early detection in preventing severe malaria cases and fatalities is pushing demand for more reliable and efficient testing solutions. These factors, combined with ongoing R&D efforts, are expected to drive continued growth in the malaria diagnostics market.

SCOPE OF STUDY:

The report analyzes the Malaria Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Segment (Rapid Diagnostic Tests, Microscopic Diagnostics, Molecular Diagnostics)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 16 Featured) -

  • 1-800MD
  • Access Bio, Inc.
  • AlphaHelix Technologies AB
  • AmeriPath, Inc.
  • Apollo Diagnostics
  • Biocan Diagnostics
  • Biohelix
  • bioMerieux Sweden AB
  • Bioperfectus Technologies
  • Biotype Diagnostics

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Malaria Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Burden of Malaria Drives Growth in Malaria Diagnostics Market
    • Technological Advancements in Rapid Diagnostic Tests Propel Adoption in Malaria-endemic Regions
    • Increased Focus on Early Detection Strengthens Business Case for Advanced Diagnostic Solutions
    • Emergence of Point-of-care Diagnostics Spurs Growth in Remote and Low-resource Settings
    • Rising Availability of Multiplex Diagnostic Platforms Propels Adoption of Comprehensive Testing
    • Increasing Global Health Initiatives to Combat Malaria Expand Market for Diagnostic Tools
    • Advancements in Molecular Diagnostics Strengthen Business Case for Accurate Malaria Detection
    • Rising Need for Accurate Surveillance Tools Accelerates Demand for Innovative Diagnostics
    • Growing Focus on Precision Medicine Generates Demand for Genotype-specific Malaria Diagnostics
    • Improved Diagnostic Technologies Propel Growth in Drug Resistance Testing for Malaria
    • Increasing Prevalence of Multi-drug-resistant Malaria Strains Drives Need for Advanced Diagnostics
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Malaria Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Malaria Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Malaria Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Malaria Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Rapid Diagnostic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Rapid Diagnostic Tests by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Rapid Diagnostic Tests by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Microscopic Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Microscopic Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Microscopic Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Molecular Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Molecular Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: USA 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: Canada 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • JAPAN
    • Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: Japan 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • CHINA
    • Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: China 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • EUROPE
    • Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Malaria Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Malaria Diagnostics by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: Europe 15-Year Perspective for Malaria Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Europe 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • FRANCE
    • Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: France 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • GERMANY
    • Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Germany 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Italy 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: UK 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 44: Spain Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Spain Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Spain 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 47: Russia Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Russia Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Russia 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Rest of Europe 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Malaria Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Malaria Diagnostics by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Asia-Pacific 15-Year Perspective for Malaria Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Asia-Pacific 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 59: Australia Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Australia Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Australia 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • INDIA
    • Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 62: India Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: India Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: India 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 65: South Korea Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: South Korea Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: South Korea 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Rest of Asia-Pacific Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Rest of Asia-Pacific 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Malaria Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Malaria Diagnostics by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Latin America 15-Year Perspective for Malaria Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Latin America 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 77: Argentina Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Argentina Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Argentina 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 80: Brazil Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Brazil Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Brazil 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 83: Mexico Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Mexico Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Mexico 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Latin America Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Rest of Latin America 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Malaria Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Malaria Diagnostics by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Middle East 15-Year Perspective for Malaria Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Middle East 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 95: Iran Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Iran Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Iran 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 98: Israel Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Israel Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Israel 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Saudi Arabia Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Saudi Arabia 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 104: UAE Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UAE Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: UAE 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of Middle East Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Rest of Middle East 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030
  • AFRICA
    • Malaria Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 110: Africa Recent Past, Current & Future Analysis for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Africa Historic Review for Malaria Diagnostics by Segment - Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Africa 15-Year Perspective for Malaria Diagnostics by Segment - Percentage Breakdown of Value Sales for Rapid Diagnostic Tests, Microscopic Diagnostics and Molecular Diagnostics for the Years 2015, 2025 & 2030

IV. COMPETITION